GLP-1 receptor agonists are most commonly prescribed to adults with type 2 diabetes who have not achieved adequate glycemic control with metformin alone or who have specific comorbidities that make GLP-1 therapy particularly beneficial
Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, et al
The released SA and silicon synergistically reinforce structural defense mechanisms by increasing callose and lignin deposition, activating the antioxidant defense system (SOD, POD, and CAT), and upregulating defense-related genes ( OsPR1a , OsWRKY45 , OsAOS2 , and OsJAMYB )
A higher score indicates more severe impairment
Bydureon BCise is an extended-release form of exenatide administered as an injection once every seven days
Half the intended dose, for the entire cycle